Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06TVG
|
|||
Former ID |
DIB011090
|
|||
Drug Name |
Inaperisone
|
|||
Synonyms |
Inapen; Inapene; Rilan; Riran; Inaperison HCl; Inaperisone hydrochloride; HN-770; HSR-770; HY-770; YM-170; YM-18170; 118230-97-]]]
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Pollakiuria [ICD-11: MF50.1; ICD-10: R35] | Discontinued in Preregistration | [1] | |
Company |
Hokuriku Seiyaku KK
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H23NO
|
|||
Canonical SMILES |
CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCC2
|
|||
InChI |
1S/C16H23NO/c1-3-14-6-8-15(9-7-14)16(18)13(2)12-17-10-4-5-11-17/h6-9,13H,3-5,10-12H2,1-2H3
|
|||
InChIKey |
VNFAARJCGSAROU-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 99323-21-4
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:134999
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nicotinic acetylcholine receptor (nAChR) | Target Info | Modulator | [2] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Highly sodium permeable acetylcholine nicotinic receptors | |||
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | ||||
WikiPathways | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003120) | |||
REF 2 | Inhibitory effect of inaperisone hydrochloride (inaperisone), a new centrally acting muscle relaxant, on the micturition reflex. Eur J Pharmacol. 1992 Mar 31;213(3):409-15. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.